menu
26-th International Trade Fair for Pharmaceuticals Products
International Medical and Pharmaceutical Business Forum
December 2-5,  Moscow, Expocentre Fairgrounds

06.06.2017
BIOTECHFARM Ltd. is a Russian manufacturer of modern dressing materials under “Vse Zazhivet®” brand The Company was established in 2000. The Company is a leading Russian manufacturer of wound [...]
06.06.2017
Bergus Ltd. is a diversified manufacturing enterprise specializing in development and production of modern ecological products from natural components. The product line includes personal-care products, cosmetics [...]
05.06.2017
Biocon Ltd, Asia’s premier biopharmaceuticals company, announced today that Ms. Pratima Rao has been appointed as Mission Director & Head of Biocon Foundation*, the CSR arm of the Company. Prior to joining [...]
05.06.2017
In 2017, BIOCAD obtained a marketing authorization for its rituximab biosimilar in Bolivia and Honduras under the trade name USMAL. First shipments will start in the beginning of the third quarter of 2017 [...]
13.04.2017
Credit: ChameleonsEye/Shutterstock A usually harmless virus may play a role in triggering celiac disease, a new study in mice suggests. The researchers found that, among mice that were genetically engineered [...]
13.04.2017
The Frankenstein of Giant Viruses Found in Sewage Plant
The Klosneuvirus was discovered here, at this wastewater treatment plant in Klosterneuburg, Austria. Credit: Marton Palatinszky New giant viruses found at an Austrian wastewater treatment plant probably evolved [...]
13.04.2017
Rockford, Illinois, is suing Mallinckrodt Pharmaceuticals over the price of the company’s drug Acthar, Business Insider reported. Specifically, Rockford is accusing the drugmaker of taking advantage of its [...]
13.04.2017
Stada Arzneimittel announced Monday that it agreed to sell itself to private-equity firms Bain Capital and Cinven for 5.3 billion euros ($5.6 billion) having determined that the bid was “the most financially appealing” [...]
13.04.2017
The filing is from Lupin’s Goa manufacturing facility Mumbai, April 08, 2017: Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Bupropion Hydrochloride Extended-Release [...]
13.04.2017
Lyon (France), April 10, 2017 — Valneva SE (“Valneva” or “the Company”), a leading pure play vaccine company, announced today that it will be holding two presentations on Lyme disease and mosquito-transmitted [...]
13.04.2017
In strong competition and after external examination, Glactone Pharma has been awarded a Vinnova (Sweden’s Innovation Agency) grant for innovative startup companies. The funded project will further investigate STAT3 as [...]
07.04.2017
According to unnamed sources, banks are preparing debt packages of up to 500 million euros to back the potential sale of Sanofi’s European contract manufacturer business Cepia, as reported in the [...]
07.04.2017
Mylan won an appeal that its proposed generic for the anticoagulant Angiomax would not infringe patents held by The Medicines Company, as reported in Yahoo!Finance. The US appeals court ruling reverses a decision [...]
07.04.2017
Study findings presented at the annual meeting of the American Association for Cancer Research (AACR) suggest that people who took aspirin regularly had a 7-percent to 11-percent lower risk of dying from cancer [...]
03.04.2017
Earlier this week, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted unanimously in favour of Roche’s subcutaneous version of Rituxan. With the agency scheduled to make an approval decision by June 26 [...]
03.04.2017
In a week of major new drug approvals, one company arguably has more to gain than its competitors. Last Tuesday, the FDA approved Dupixent, a first-in-class treatment for moderate-to-severe atopic dermatitis; [...]
03.04.2017
According to two people familiar with the matter, Capital International Private Equity Fund has acquired about 3 percent of Intas Pharmaceuticals for $107 million from ChrysCapital, reported livemint.com. One of the [...]
30.03.2017
Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced that data on its [...]
30.03.2017
WASHINGTON, March 29, 2017 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will [...]
22.03.2017
Gilead Sciences Canada, Inc. ( Gilead Canada ) today announced, effective March 21, 2017 , British Columbia will provide public access to EPCLUSA™ (sofosbuvir/velpatasvir) tablets, the first once-daily, pan-genotypic single [...]